Roberto Díez Martínez

Roberto Diez-Martinez, PhD, currently serves as Chief Operating Officer, President, and CEO & Co-Founder of Telum Therapeutics, a role initiated in 2019. Prior experience includes serving as CEO & Co-Founder of Ikan Biotech from 2015 to 2019 and as a Postdoctoral Researcher at the Spanish National Research Council, where studies focused on enzybiotics and antimicrobial agents. Academic credentials comprise a Doctor of Philosophy in Biochemistry, Molecular Biology, and Biomedicine from Universidad Complutense de Madrid and an Executive MBA from EAE Business School. Additional educational achievements include a Master’s in Project Management and a Master of Science in Microbiology. Research interests are centered around the development of new antimicrobial compounds and enzybiotics, with extensive study in animal models.